Long-Term Follow-Up with Ross Procedure at a Single Institution in China

Abstract

Background Although the Ross operation requires double-valve replacement for aortic valve disease, it has been shown to provide excellent hemodynamic results and is associated with low morbidity and mortality rates. We reviewed our long-term experience after completion of the Ross procedure.

Methods Between October 1994 and February 2009, 58 consecutive patients underwent a Ross procedure at our institution. The right ventricular outñow tract was repaired with a cryopreserved pulmonary homograft. All patients were scheduled for a yearly study thereafter that ended at the time of death or at closure of the follow-up visit. Mean follow-up was 8.2 ± 3.5 years (range: 1.8 to 16.2 years).

Results There were two early deaths (3%) and one late death (2%). Actuarial survival at 16 years was 94.8 ± 3.1%. One patient required reoperation and died during reoperation 1.5 years after his first Ross operation. Of the 55 survival patients, 42 patients (76%) were in NYHA functional class I and 13 patients (24%) were in NYHA functional class II. Grade 1 or grade 2 autograft regurgitation was observed in seven patients (12%) at 1 year after the surgery. The sinus of Valsalva diameters were all <40 mm in these seven patients. Freedom from hemodynamically relevant autograft regurgitation was 88 ± 2.8% at 16 years. After surgery, left ventricular function was significantly improved and left ventricular end-diastolic diameter recovered to normal over the long term. None of the patients required reoperation due to pulmonary homograft failure.

Conclusions The Ross procedure can be safely performed in patients with aortic valve disease. To date, mortality, morbidity, and reoperation rates are very low. Reasons for these superior results may include the following: (1) the diameter of the aortic valve annulus matching that of the pulmonary valve and (2) patients were monitored with antihypertensive medications to keep systolic blood pressure under 120 mm Hg to delay pressure lesions to the pulmonary autograft.

Keywords

aortic valve and root - heart valve Surgery - pulmonary valve

• References

• 1 Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967; 2 (7523) 956-958
• 2 Ross DN, Jackson M, Davies J. The pulmonary autograft—a permanent aortic valve. Eur J Cardiothorac Surg 1992; 6 (3) 113-116 , discussion 117
• 3 Raja SG, Pozzi M. Growth of pulmonary autograft after Ross operation in pediatric patients. Asian Cardiovasc Thorac Ann 2004; 12 (4) 285-290
• 4 Hörer J, Stierle U, Bogers AJ , et al. Re-interventions on the autograft and the homograft after the Ross operation in children. Eur J Cardiothorac Surg 2010; 37 (5) 1008-1014
• 5 Oury JH, Hiro SP, Maxwell JM, Lamberti JJ, Duran CM. The Ross Procedure: current registry results. Ann Thorac Surg 1998; 66 (6, Suppl): S162-S165
• 6 Böhm JO, Hemmer W, Rein JG , et al. A single-institution experience with the Ross operation over 11 years. Ann Thorac Surg 2009; 87 (2) 514-520
• 7 Brown JW, Ruzmetov M, Shahriari A, Rodefeld MD, Mahomed Y, Turrentine MW. Midterm results of Ross aortic valve replacement: a single-institution experience. Ann Thorac Surg 2009; 88 (2) 601-607 , discussion 607–608
• 8 Pasquali SK, Shera D, Wernovsky G , et al. Midterm outcomes and predictors of reintervention after the Ross procedure in infants, children, and young adults. J Thorac Cardiovasc Surg 2007; 133 (4) 893-899
• 9 Pasquali SK, Cohen MS, Shera D, Wernovsky G, Spray TL, Marino BS. The relationship between neo-aortic root dilation, insufficiency, and reintervention following the Ross procedure in infants, children, and young adults. J Am Coll Cardiol 2007; 49 (17) 1806-1812
• 10 Alsoufi B, Manlhiot C, Fadel B , et al. The Ross procedure in children: preoperative haemodynamic manifestation has significant effect on late autograft re-operation. Eur J Cardiothorac Surg 2010; 38 (5) 547-555
• 11 Elkins RC, Lane MM, McCue C. Ross operation in children: late results. J Heart Valve Dis 2001; 10 (6) 736-741
• 12 Moidl R, Simon P, Aschauer C , et al. Does the Ross operation fulfil the objective performance criteria established for new prosthetic heart valves?. J Heart Valve Dis 2000; 9 (2) 190-194
• 13 Carr-White GS, Afoke A, Birks EJ , et al. Aortic root characteristics of human pulmonary autografts. Circulation 2000; 102 (19) (Suppl. 03) III15-III21
• 14 Elkins RC, Lane MM, McCue C, Ward KE. Pulmonary autograft root replacement: mid-term results. J Heart Valve Dis 1999; 8 (5) 499-503 , discussion 503–506
• 15 Hanke T, Stierle U, Boehm JO , et al; German Ross Registry. Autograft regurgitation and aortic root dimensions after the Ross procedure: the German Ross Registry experience. Circulation 2007; 116 (11, Suppl): I251-I258
• 16 Sievers HH, Stierle U, Charitos EI , et al. Fourteen years' experience with 501 subcoronary Ross procedures: surgical details and results. J Thorac Cardiovasc Surg 2010; 140 (4) 816-822 , 822, e1–e5
• 17 Al Rashidi F, Bhat M, Höglund P, Meurling C, Roijer A, Koul B. The modified Ross operation using a Dacron prosthetic vascular jacket does prevent pulmonary autograft dilatation at 4.5-year follow-up. Eur J Cardiothorac Surg 2010; 37 (4) 928-933
• 18 Brown JW, Ruzmetov M, Shahriari AP, Rodefeld MD, Mahomed Y, Turrentine MW. Modification of the Ross aortic valve replacement to prevent late autograft dilatation. Eur J Cardiothorac Surg 2010; 37 (5) 1002-1007
• 19 Frigiola A, Varrica A, Satriano A , et al; Surgical and Clinical Outcome REsearch (SCORE) Group. Neoaortic valve and root complex evolution after Ross operation in infants, children, and adolescents. Ann Thorac Surg 2010; 90 (4) 1278-1285
• 20 Brown JW, Ruzmetov M, Rodefeld MD, Turrentine MW. Right ventricular outflow tract reconstruction in Ross patients: does the homograft fare better?. Ann Thorac Surg 2008; 86 (5) 1607-1612